Search Page

1

Cite

Share

Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic.

Scarpellini E, Fagoonee S, Rinninella E, Rasetti C, Aquila I, Larussa T, Ricci P, Luzza F, Abenavoli L. Scarpellini E, et al. Among authors: larussa t. J Clin Med. 2020 Aug 3;9(8):2488. doi: 10.3390/jcm9082488. J Clin Med. 2020. PMID: 32756323 Free PMC article. Review.

Cite

Share

2

Cite

Share

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, Modeo ME, Rodino' S, D'Amico T, Sebkova L, Sacca' N, Di Giulio E, Luzza F, Imeneo M, Larussa T, Di Rosa S, Annese V, Danese S, Gasbarrini A. Tursi A, et al. Among authors: larussa t. Am J Gastroenterol. 2010 Oct;105(10):2218-27. doi: 10.1038/ajg.2010.218. Epub 2010 Jun 1. Am J Gastroenterol. 2010. PMID: 20517305 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better.

Larussa T, Imeneo M, Luzza F. Larussa T, et al. Int J Mol Sci. 2019 Mar 20;20(6):1390. doi: 10.3390/ijms20061390. Int J Mol Sci. 2019. PMID: 30897691 Free PMC article. Review.

Cite

Share

4

Cite

Share

Liver Cirrhosis Complications Management at the Emergency Department.

Scarpellini E, Luigiano C, Svegliati-Baroni G, Dumitrascu D, Larussa T, Santori V, Luzza F, Abenavoli L. Scarpellini E, et al. Among authors: larussa t. Rev Recent Clin Trials. 2020;15(4):331-338. doi: 10.2174/1574887115666200603160816. Rev Recent Clin Trials. 2020. PMID: 32493202

Cite

Share

5

Cite

Share

Potential role of nutraceutical compounds in inflammatory bowel disease.

Larussa T, Imeneo M, Luzza F. Larussa T, et al. World J Gastroenterol. 2017 Apr 14;23(14):2483-2492. doi: 10.3748/wjg.v23.i14.2483. World J Gastroenterol. 2017. PMID: 28465632 Free PMC article. Review.

Cite

Share

6

Cite

Share

Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease.

Abenavoli L, Scarpellini E, Pellicano R, Fagoonee S, Larussa T, Luzza F. Abenavoli L, et al. Among authors: larussa t. Minerva Med. 2020 Dec;111(6):526-528. doi: 10.23736/S0026-4806.20.07089-5. Epub 2020 Nov 3. Minerva Med. 2020. PMID: 33140925 No abstract available.

Cite

Share

7

Cite

Share

T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection.

Jafarzadeh A, Larussa T, Nemati M, Jalapour S. Jafarzadeh A, et al. Among authors: larussa t. Microb Pathog. 2018 Mar;116:227-236. doi: 10.1016/j.micpath.2018.01.040. Epub 2018 Jan 31. Microb Pathog. 2018. PMID: 29407232 Review.

Cite

Share

8

Cite

Share

Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview.

Spagnuolo R, Abenavoli L, Larussa T, Iannelli C, Pellicano R, Fagoonee S, Doldo P, Luzza F. Spagnuolo R, et al. Among authors: larussa t. Minerva Gastroenterol Dietol. 2020 Dec 3. doi: 10.23736/S1121-421X.20.02819-6. Online ahead of print. Minerva Gastroenterol Dietol. 2020. PMID: 33267572

Cite

Share

9

Cite

Share

Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients.

Larussa T, Boccuto L, Luzza F, Abenavoli L. Larussa T, et al. Minerva Gastroenterol Dietol. 2020 May 13. doi: 10.23736/S1121-421X.20.02710-5. Online ahead of print. Minerva Gastroenterol Dietol. 2020. PMID: 32403893 No abstract available.

Cite

Share

10

Cite

Share

COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey.

Spagnuolo R, Larussa T, Iannelli C, Cosco C, Nisticò E, Manduci E, Bruno A, Boccuto L, Abenavoli L, Luzza F, Doldo P. Spagnuolo R, et al. Among authors: larussa t. Medicina (Kaunas). 2020 Aug 13;56(8):407. doi: 10.3390/medicina56080407. Medicina (Kaunas). 2020. PMID: 32823727 Free PMC article.

Cite

Share